Navigation Links
Postmenopausal Women May Benefit From Isoflavones Therapy

Phytoestrogens, estrogen-like compounds, have been found to enhance mental sharpness and mood among postmenopausal women, a new study has found//. This finding highlights that the plant derivatives can be used in the treatment of hormonal imbalances occurring during menopause.

Older women who were given phytoestrogen tablets, in the form of 60mg isoflavones had superior cognitive performance and better mood, reports the study, published in the Fertility and Sterility journal.

The study included 78 post-menopausal women and was randomized into two different groups, one group was assigned to phytoestrogen tablet while the other group was assigned placebo for a period of 6 months. The study participants provided with the placebo were provided the phytoestrogen tablet at the end of 6 months. The researchers then analyzed the cognition and mood function in all the study participants.

Postmenopausal women administered phytoestrogen scored better in 14 of the 17 tests when compared to their counterparts provided with placebo. No significant difference between the two groups was however noted in the 6 tests.

When questioned about the preference for a specific treatment, 49 women said that they would prefer the phytoestrogen tablet while 9 others preferred the placebo. Additionally, another 18 women said that they had no preference at all.

The present study highlights that these novel compound can be used to provide symptomatic relief to psychological disturbances, associated with menopause.

Source: Eurekalert
'"/>




Page: 1

Related medicine news :

1. Exercise The Ideal Solution For Postmenopausal Women
2. Insight for Hot Flashes In Postmenopausal Women
3. New Insight In Periodontal Disease In Postmenopausal Women
4. Low bone mass in Postmenopausal Women
5. Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women
6. Risks/Benefits of Osteoporosis Drug Use in Postmenopausal Women
7. Women suffer from sexual dysfunction too
8. Women find difficulty in calling it Quits
9. Women recognise faces better
10. Women more susceptible to brain damage from ecstasy
11. Good News For Women With Gestational Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... , ... Cellairis is a worldwide mobile device and computer repair franchise that ... and Samsung Galaxy devices with premium parts and accessories. Cellairis has recently set-up ... accessibility for customers. While customers do their shopping, Cellairis can accomplish a number of ...
(Date:12/9/2016)... ... ... An inventor from Cana, Va., wanted to fulfill the need for a ... , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. It is ... in a matter of minutes, or even seconds. The SAFETY STRAP FOR AMPUTEES is ...
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
(Date:12/8/2016)... Islandia, NY (PRWEB) , ... December 08, 2016 ... ... company, is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture ... published in JMIR Medical Informatics . , Results of the comparative usability ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Research and Markets has announced the addition of the "Endodontic Supplies ... ... the worldwide markets for Endodontic Supplies in US$ Thousand. The report provides separate ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a six-year ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: